158 related articles for article (PubMed ID: 18565966)
41. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate.
Fenger-Eriksen C; Anker-Møller E; Heslop J; Ingerslev J; Sørensen B
Br J Anaesth; 2005 Mar; 94(3):324-9. PubMed ID: 15608046
[TBL] [Abstract][Full Text] [Related]
42. HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function.
Sossdorf M; Marx S; Schaarschmidt B; Otto GP; Claus RA; Reinhart K; Hartog CS; Lösche W
Crit Care; 2009; 13(6):R208. PubMed ID: 20028511
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram.
Lak M; Scharling B; Blemings A; Sharifian R; Maleki Z; Daraee A; Arjmand AR; Hedner U
Haemophilia; 2008 Jan; 14(1):103-10. PubMed ID: 18070065
[TBL] [Abstract][Full Text] [Related]
44. Hydroxyethyl starch is superior to lactated Ringer as a replacement fluid in a pig model of acute normovolaemic haemodilution.
Otsuki DA; Fantoni DT; Margarido CB; Marumo CK; Intelizano T; Pasqualucci CA; Costa Auler JO
Br J Anaesth; 2007 Jan; 98(1):29-37. PubMed ID: 17130138
[TBL] [Abstract][Full Text] [Related]
45. General haemostatic agents--fact or fiction?
Hedner U
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
[TBL] [Abstract][Full Text] [Related]
46. Variability of thromboelastographic responses following the administration of rFVIIa to haemophilia A dogs supports the individualization of therapy with a global test of haemostasis.
Othman M; Powell S; Hopman WM; Lillicrap D
Haemophilia; 2010 Nov; 16(6):919-25. PubMed ID: 20609015
[TBL] [Abstract][Full Text] [Related]
47. Effect of in vitro hemodilution with hydroxyethyl starch and dextran on the activity of plasma clotting factors.
Petroianu GA; Maleck WH; Koetter KP; Liu J; Schmitt A
Crit Care Med; 2003 Jan; 31(1):250-4. PubMed ID: 12545024
[TBL] [Abstract][Full Text] [Related]
48. Evaluating and monitoring the efficacy of recombinant activated factor VIIa in patients with haemophilia and inhibitors.
Qi X; Zhao Y; Li K; Fan L; Hua B
Blood Coagul Fibrinolysis; 2014 Oct; 25(7):754-60. PubMed ID: 24806320
[TBL] [Abstract][Full Text] [Related]
49. Effects of in vitro hemodilution with crystalloids, colloids, and plasma on canine whole blood coagulation as determined by kaolin-activated thromboelastography.
Morris BR; deLaforcade A; Lee J; Palmisano J; Meola D; Rozanski E
J Vet Emerg Crit Care (San Antonio); 2016; 26(1):58-63. PubMed ID: 26220153
[TBL] [Abstract][Full Text] [Related]
50. Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs.
Thyes C; Madjdpour C; Frascarolo P; Buclin T; Bürki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
Anesthesiology; 2006 Dec; 105(6):1228-37. PubMed ID: 17122586
[TBL] [Abstract][Full Text] [Related]
51. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
[TBL] [Abstract][Full Text] [Related]
52. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
Sørensen B; Ingerslev J
Thromb Haemost; 2006 Oct; 96(4):446-53. PubMed ID: 17003921
[TBL] [Abstract][Full Text] [Related]
53. In vitro effects of lactated Ringer's solution, hypertonic saline, hydroxyethyl starch, hypertonic saline/hydroxyethyl starch, and mannitol on thromboelastographic variables of canine whole blood.
Chan A; Hughes D; Tennent-Brown BS; Boller M
J Vet Emerg Crit Care (San Antonio); 2020 May; 30(3):255-263. PubMed ID: 32077234
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery.
Skhirtladze K; Base EM; Lassnigg A; Kaider A; Linke S; Dworschak M; Hiesmayr MJ
Br J Anaesth; 2014 Feb; 112(2):255-64. PubMed ID: 24169821
[TBL] [Abstract][Full Text] [Related]
55. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
56. In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography.
Mortier E; Ongenae M; De Baerdemaeker L; Herregods L; Den Blauwen N; Van Aken J; Rolly G
Anaesthesia; 1997 Nov; 52(11):1061-4. PubMed ID: 9404167
[TBL] [Abstract][Full Text] [Related]
57. A comparison of the effects of a 4% modified fluid gelatin and a 6% hydroxyethyl starch on haemodilution, colloid osmotic pressure, haemostasis and renal parameters in healthy ponies.
Gratwick Z; Viljoen A; Page PC; Goddard A; Fosgate GT; Lyle CH
Equine Vet J; 2017 May; 49(3):363-368. PubMed ID: 27258662
[TBL] [Abstract][Full Text] [Related]
58. NovoSeven as a universal haemostatic agent.
Hedner U
Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S107-11. PubMed ID: 10850574
[TBL] [Abstract][Full Text] [Related]
59. Retracted: Influence of volume replacement with different HES-solutions on microcirculatory blood flow in cardiac surgery.
Boldt J; Zickmann B; Rapin J; Hammermann H; Dapper F; Hempelmann G
Acta Anaesthesiol Scand; 1994 Jul; 38(5):432-8. PubMed ID: 7524255
[TBL] [Abstract][Full Text] [Related]
60. Effects of acidosis, alkalosis, hyperthermia and hypothermia on haemostasis: results of point-of-care testing with the thromboelastography analyser.
Ramaker AJ; Meyer P; van der Meer J; Struys MM; Lisman T; van Oeveren W; Hendriks HG
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):436-9. PubMed ID: 19491662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
